Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name APG101
Trade Name
Synonyms APG-101|APG 101|Asunercept|Apocept|CAN008|CAN-008
Drug Descriptions

APG101, a glycosylated fusion protein comprised of the CD95 extracellular domain and of the IgG1 Fc domain, which binds to CD95L and prevents binding to CD95, potentially leading to decreased tumor cell invasion and increased radiotherapy efficacy (PMID: 29453321, PMID: 25850884, PMID: 22446296).

CAS Registry Number 1450882-18-4
NCIT ID C90562


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
APG101 APG101 0 1
APG101 + Radiotherapy APG101 Radiotherapy 0 0

Additional content available in CKB BOOST